184 related articles for article (PubMed ID: 7616275)
1. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes.
Roessler K; Suchanek G; Breitschopf H; Kitz K; Matula C; Lassmann H; Koos WT
J Neurosurg; 1995 Aug; 83(2):291-7. PubMed ID: 7616275
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops.
Hermanson M; Funa K; Hartman M; Claesson-Welsh L; Heldin CH; Westermark B; Nistér M
Cancer Res; 1992 Jun; 52(11):3213-9. PubMed ID: 1317261
[TBL] [Abstract][Full Text] [Related]
3. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
4. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
[TBL] [Abstract][Full Text] [Related]
5. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
6. Expression of tissue factor correlates with grade of malignancy in human glioma.
Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
Cancer; 1996 May; 77(9):1877-83. PubMed ID: 8646688
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
Yu S; Pu P; Jiang D; An T; Guan X; Yang L
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
[TBL] [Abstract][Full Text] [Related]
9. Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas.
Hayashi S; Yamamoto M; Ueno Y; Ikeda K; Ohshima K; Soma G; Fukushima T
Neurol Med Chir (Tokyo); 2001 Apr; 41(4):187-95. PubMed ID: 11381677
[TBL] [Abstract][Full Text] [Related]
10. Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy.
Krishna M; Smith TW; Recht LD
J Neurosurg; 1995 Dec; 83(6):1017-22. PubMed ID: 7490615
[TBL] [Abstract][Full Text] [Related]
11. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
12. Evidence for telomerase involvement in the angiogenesis of astrocytic tumors: expression of human telomerase reverse transcriptase messenger RNA by vascular endothelial cells.
Pallini R; Pierconti F; Falchetti ML; D'Arcangelo D; Fernandez E; Maira G; D'Ambrosio E; Larocca LM
J Neurosurg; 2001 Jun; 94(6):961-71. PubMed ID: 11409526
[TBL] [Abstract][Full Text] [Related]
13. The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors.
Tran NL; McDonough WS; Donohue PJ; Winkles JA; Berens TJ; Ross KR; Hoelzinger DB; Beaudry C; Coons SW; Berens ME
Am J Pathol; 2003 Apr; 162(4):1313-21. PubMed ID: 12651623
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
Zhang X; Fei Z; Bu X; Zhen H; Zhang Z; Gu J; Chen Y
J Surg Oncol; 2000 Jun; 74(2):90-4. PubMed ID: 10914816
[TBL] [Abstract][Full Text] [Related]
16. Defective expression of interferon-gamma, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and interleukin-6 in activated peripheral blood lymphocytes from glioma patients.
Urbani F; Maleci A; La Sala A; Lande R; Ausiello CM
J Interferon Cytokine Res; 1995 May; 15(5):421-9. PubMed ID: 7648444
[TBL] [Abstract][Full Text] [Related]
17. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs.
Nabors LB; Gillespie GY; Harkins L; King PH
Cancer Res; 2001 Mar; 61(5):2154-61. PubMed ID: 11280780
[TBL] [Abstract][Full Text] [Related]
18. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of interleukin-1 beta and interleukin-6 in human brain tumors.
Lichtor T; Libermann TA
Neurosurgery; 1994 Apr; 34(4):669-72; discussion 672-3. PubMed ID: 8008165
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
